Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Carcinoma, Basal Cell 2Basal Cell Nevus Syndrome 2Solid Tumor 1Neoplasms 1Keratosis, Actinic 1

Interventions

HhAntag691 14sonidegib 4methyl 5-aminolevulinate 3Photochemotherapy 3Aminolevulinic Acid 3tazarotene 2cemiplimab 2IPI-926 2Drug Evaluation 21-phenyl-3,3-dimethyltriazene 2silmitasertib 1remetinostat 1prednylidene 1pembrolizumab 1deltacortene 1Tacrolimus 1Risk Factors 1Prednisone 1Nivolumab 1NVP-BKM120 1Mohs Surgery 1Mindfulness 1Midazolam 1Itraconazole 1Ipilimumab 1IFL protocol 1Folfox protocol 1Fluorouracil 1CTLA-4 Antigen 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Carcinoma, Basal Cell × tazarotene × Clear all
NCT00489086 2020-10-29

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face

UCSF Benioff Children's Hospital Oakland

Phase 2 Completed
36 enrolled 7 charts
Dermatologic

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell, Neoplasms

NCT00783965 2016-02-11

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back

UCSF Benioff Children's Hospital Oakland

Phase 2 Completed
34 enrolled 9 charts
Dermatologic

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡